Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16776
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRobertson, Marcus-
dc.contributor.authorMajumdar, Avik-
dc.contributor.authorBoyapati, Ray-
dc.contributor.authorChung, William-
dc.contributor.authorWorland, Tom-
dc.contributor.authorTerbah, Ryma-
dc.contributor.authorWei, James-
dc.contributor.authorLontos, Steve-
dc.contributor.authorAngus, Peter W-
dc.contributor.authorVaughan, Rhys B-
dc.date2015-10-26-
dc.date.accessioned2017-08-10T00:44:39Z-
dc.date.available2017-08-10T00:44:39Z-
dc.date.issued2016-06-
dc.identifier.citationGastrointestinal Endoscopy 2016; 83(6): 1151-1160en_US
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/16776-
dc.description.abstractBACKGROUND AND AIMS: The American College of Gastroenterology recommends early risk stratification in patients presenting with upper GI bleeding (UGIB). The AIMS65 score is a risk stratification score previously validated to predict inpatient mortality. The aim of this study was to validate the AIMS65 score as a predictor of inpatient mortality in patients with acute UGIB and to compare it with established pre- and postendoscopy risk scores. METHODS: ICD-10 (International Classification of Diseases, Tenth Revision) codes identified patients presenting with UGIB requiring endoscopy. All patients were risk stratified by using the AIMS65, Glasgow-Blatchford score (GBS), pre-endoscopy Rockall, and full Rockall scores. The primary outcome was inpatient mortality. Secondary outcomes were a composite endpoint of inpatient mortality, rebleeding, and endoscopic, radiologic, or surgical intervention; blood transfusion requirement; intensive care unit (ICU) admission; rebleeding; and hospital length of stay. The area under the receiver-operating characteristic curve (AUROC) was calculated for each score. RESULTS: Of the 424 study patients, 18 (4.2%) died and 69 (16%) achieved the composite endpoint. The AIMS65 score was superior to both the GBS (AUROC, 0.80 vs 0.76, P < .027) and the pre-endoscopy Rockall score (0.74, P = .001) and equivalent to the full Rockall score (0.78, P = .18) in predicting inpatient mortality. The AIMS65 score was superior to all other scores in predicting the need for ICU admission and length of hospital stay. AIMS65, GBS, and full Rockall scores were equivalent (AUROCs, 0.63 vs 0.62 vs 0.63, respectively) and superior to pre-endoscopy Rockall (AUROC, 0.55) in predicting the composite endpoint. GBS was superior to all other scores for predicting blood transfusion. CONCLUSION: The AIMS65 score is a simple risk stratification score for UGIB with accuracy superior to that of GBS and pre-endoscopy Rockall scores in predicting in-hospital mortality and the need for ICU admission.en_US
dc.subjectEsophageal Diseasesen_US
dc.subjectGastrointestinal Hemorrhageen_US
dc.subjectHospital Mortalityen_US
dc.subjectRisk Assessmenten_US
dc.titleRisk stratification in acute upper GI bleeding: comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring systemsen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleGastrointestinal Endoscopyen_US
dc.identifier.affiliationepartment of Gastroenterology, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationLiver Transplant Unit, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/26515955en_US
dc.identifier.doi10.1016/j.gie.2015.10.021en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on May 8, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.